ReviewThe Lancet. Global health2026
Intersectionality of cancer disparities in south Asia.
Review in The Lancet. Global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Health Systems Analysis of Global Head and Neck Cancer Outcomes.The Laryngoscope · 2026Article
- Artificial Intelligence and the Global Radiotherapy Gap.JCO global oncology · 2026Article
- Feasibility and Policy Implications of a Pragmatically Adapted Pediatric-Inspired Induction Regimen for Adults with Acute Lymphoblastic Leukemia in a Resource-Restricted Setting: A Prospective Observational Study.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Member states of the South Asian Association for Regional Cooperation (SAARC), home to over 2 billion people, carry a disproportionate cancer burden shaped by stark heterogeneity in risk, access, and outcomes. Beyond large proportions of people living in poverty in the context of frail infrastructure, inequities are compounded by intersecting identities, including gender, caste, religion, language, geography, and sexual or gender minority status. Commonly, women face delayed diagnosis amid low human papillomavirus vaccination and screening; rural communities confront distance and cost; Dalit, indigenous, and refugee groups experience structural exclusion; and language discordance and cultural beliefs impede timely care. Financial toxicity is pervasive, pushing households into poverty despite emerging insurance schemes. Drawing on targeted literature from SAARC countries, we argue for an intersectionality-informed agenda: strengthen registries and national cancer control programmes with disaggregated data; expand equitable financing and workforce deployment; embed cultural competence and bias mitigation in clinical training; and prioritise research that models intersecting risks. Implementing context-appropriate strategies will be essential for achieving equitable cancer control across the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.